Drugs

The Special Access Programme (SAP) provides access to nonmarketed drugs for practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable. The SAP authorizes a manufacturer to sell a drug that cannot otherwise be sold or distributed in Canada. Drugs considered for release by the SAP include pharmaceutical, biologic, and radio-pharmaceutical products not approved for sale in Canada.

	Facts sheets
	Forms
	Guidance Documents

Fact Sheets

Special Access Programme Fact Sheet Date: 2002-11-22

Forms

	Special Access Request Form Date: 2004-11-17
	Future Use Records Form Date: 2003-08-24

Guidance Documents

	Notice - Administration of the Special Access Programme with respect to 714-X Date: 2006-10-02
	Instructions for Making a Future Use Special Access Request 2003-2004 Date: 2003-08-24
	Special Access Programme (SAP) Instructions for Making a Special Access Request 2003-2004 Date: 2003-08-24